Toxicology Screening in Sports-Related Sudden Cardiac Death – American College of Cardiology
Thomas C. Crawford, MD, FACC
Thomas C. Crawford, MD, FACC
Objective The management of blood pressure (BP) in acute ischaemic stroke remains a subject of controversy. This investigation aimed to explore the relationship between 24-hour…
The VICTORION-INIATATE study demonstrated that initiating inclisiran, a highly potent lipid-lowering therapy, upon failure to achieve lipid targets with statins, yielded superior outcomes compared to…
With the approval of mavacamten, patients with hypertrophic cardiomyopathy now have more options, Steve Ommen says.
The American Heart Association’s new Workforce Well-being Scorecard is designed to help employers evaluate the culture of health and well-being within their workforces to identify…
A new guideline on hypertrophic cardiomyopathy endorses the use of cardiac myosin inhibitors for certain patients with obstructive HCM and encourages exercise in all patients…
Interventional cardiologist Foluso Fakorede, MD, says everything from limited specialists to a lack of sidewalks are causing a disproportionate rate of minorities to be caught…
Aim The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic ca
British Heart Foundation, Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom. (D.T.Y.A., A.K., R.S., C.B.) British Heart Foundation,…
With the approval of mavacamten, patients with hypertrophic cardiomyopathy now have more options, Steve Ommen says.